Advertisement

Breast Cancer Research and Treatment

, Volume 167, Issue 3, pp 703–708 | Cite as

The value of embedding: integrated palliative care for patients with metastatic breast cancer

  • M. Rabow
  • R. Small
  • A. Jow
  • M. Majure
  • A. Chien
  • M. Melisko
  • J. Belkora
  • L. J. Esserman
  • H. Rugo
Clinical trial

Abstract

Purpose

The American Society of Clinical Oncology recommends concurrent palliative care (PC) for patients with metastatic cancer. Recent data show benefits of early PC (at least 90 days before death). However, little is known about PC among patients who die from metastatic breast cancer.

Methods

Patients with metastatic breast cancer at a comprehensive cancer center. Analysis of medical records and clinician and patient surveys. Assess referral patterns and value to patients at the end of life (EOL) of a specialty PC service embedded in a breast oncology program; compare to a prior period of stand-alone PC.

Results

In the 18-month study period, oncologists referred for palliative care 105 of their 515 (20.4%) patients; 59 (11.5%) patients were seen by the PC physician. Of the 38 referred patients who died, 23 (60.5%) were seen by embedded PC and all 23 received PC within 90 days of death; 0 of 18 decedents with data available for analysis had ICU stays within 30 days of death. In an earlier 24-month period of stand-alone PC, 43 patients died after receiving PC, but only 11 (25.5%) received PC within 90 days of death (p < 0.01) and 7 of 43 had ICU stays within 30 days of death (p = 0.074).

Conclusions

Embedded PC was well-received by patients and oncologists, increased early PC referrals, and improved EOL care. Avoidable, unnecessary health care utilization at the end of life, such as ICU stays in the last month of life, represent an important potential reduction in patient suffering and system costs.

Keywords

Palliative care Breast cancer Concurrent care End-of-life care 

Notes

Funding

The ABC clinic is partially supported by a Grant from the UCSF Give Breast Cancer the Boot Fund. The research evaluation itself received no funding.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Metastatic Breast Cancer: The National Breast Cancer Foundation. www.nationalbreastcancer.org. Available at: http://www.nationalbreastcancer.org/metastatic-breast-cancer. Accessed 10th August 2015
  2. 2.
    Gattellari M, Voigt KJ, Butow PN, Tattersall MHN (2002) When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol Off J Am Soc Clin Oncol 20:503–513CrossRefGoogle Scholar
  3. 3.
    Hamer J et al (2017) Quality of life (QOL) and symptom burden (SB) in patients with breast cancer. Support Care Cancer 25:409–419CrossRefPubMedGoogle Scholar
  4. 4.
    O’Connor TL et al (2015) Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center. J Palliat Med 18:50–55CrossRefPubMedGoogle Scholar
  5. 5.
    Smith TJ et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol Off J Am Soc Clin Oncol 30:880–887CrossRefGoogle Scholar
  6. 6.
    Marwick C (2001) IOM calls for improvements in palliative care. J Natl Cancer Inst 93:1128CrossRefPubMedGoogle Scholar
  7. 7.
    Levy MH et al (2009) NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Cancer Netw JNCCN 7:436–473CrossRefGoogle Scholar
  8. 8.
    Cardoso F et al (2017) 3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3). Ann Oncol.  https://doi.org/10.1093/annonc/mdx036 Google Scholar
  9. 9.
    Rabow M et al (2013) Moving upstream: a review of the evidence of the impact of outpatient palliative care. J Palliat Med 16:1540–1549CrossRefPubMedGoogle Scholar
  10. 10.
    Temel JS et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRefPubMedGoogle Scholar
  11. 11.
    Zimmermann C et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730CrossRefPubMedGoogle Scholar
  12. 12.
    Prince-Paul M, Burant CJ, Saltzman JN, Teston LJ, Matthews CR (2010) The effects of integrating an advanced practice palliative care nurse in a community oncology center: a pilot study. J. Support. Oncol. 8:21–27PubMedGoogle Scholar
  13. 13.
    Scibetta C, Kerr K, Mcguire J, Rabow MW (2016) The costs of waiting: implications of the timing of palliative care consultation among a cohort of decedents at a comprehensive cancer center. J. Palliat. Med. 19:69–75CrossRefPubMedGoogle Scholar
  14. 14.
    Quality Oncology Practice Initiative (Last accessed February 8, 2015). Available at: http://qopi.asco.org/. Accessed 16th January 2017
  15. 15.
    National Voluntary Consensus Standards for Quality of Cancer Care. National Quality Forum Available at: www.qualityforum.org/Publications/2009/05/National_Voluntary_Consensus_Standards_for_Quality_of_Cancer_Care.aspx. Accessed 1st September 2016

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Division of General Internal Medicine, Department of MedicineUniversity of CaliforniaSan FranciscoUSA
  2. 2.The ABC ClinicUniversity of CaliforniaSan FranciscoUSA
  3. 3.Princeton UniversityPrincetonUSA
  4. 4.Division of Hematology and Oncology, Department of MedicineUniversity of CaliforniaSan FranciscoUSA
  5. 5.Institute for Health Policy StudiesUniversity of CaliforniaSan FranciscoUSA
  6. 6.Departments of Surgery and RadiologyUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations